Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates

4 Feb 2006

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mosquito-borne diseases and control
Share to Viral Infections and Outbreaks Research
Share to Viral Infections and Vectors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 16490289
DOI: 10.1016/j.vaccine.2006.01.036

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primatesPMID 16490289Read ↗

Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in miceSemantic proximity Read ↗

Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoesSemantic proximity Read ↗

Can non-human primates serve as models for investigating dengue disease pathogenesis?Semantic proximity Read ↗

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced diseaseSemantic proximity Read ↗

Evaluation of immunity and protective efficacy of a dengue-3 premembrane and envelope DNA vaccine in Aotus nancymae monkeysSemantic proximity Read ↗

Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 virusesSemantic proximity Read ↗

Antibodies induced by dengue virus type 1 and 2 envelope domain III recombinant proteins in monkeys neutralize strains with different genotypes.Semantic proximity Read ↗

Viremia and Immunogenicity in Nonhuman Primates of a Tetravalent Yellow Fever–Dengue Chimeric Vaccine: Genetic Reconstructions, Dose Adjustment, and Antibody Responses against Wild-type Dengue Virus IsolatesSemantic proximity Read ↗

Structures and Functions of the Envelope Glycoprotein in Flavivirus InfectionsSemantic proximity Read ↗

The dengue virus non-structural 1 protein: Risks and benefitsSemantic proximity Read ↗

A dengue-2 Envelope fragment inserted within the structure of the P64k meningococcal protein carrier enables a functional immune response against the virus in miceSemantic proximity Read ↗

Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: Their immunity and protective efficacy in miceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.